Thursday, September 17, 2015

Cancer Research: Scientists discover how cells overpower cancer drug ♦ New catalyst yields more accurate PSA test ♦ Potential new therapeutic approach found for liver cell cancer

Potential new therapeutic approach found for liver cell cancer The growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
Research breakthrough in fight against muscle wasting diseases It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting, but a new study could be a game changer for patients, improving both quality of life and longevity
New catalyst yields more accurate PSA test Chemists have developed a catalyst that improves the sensitivity of the standard PSA test over 100-fold. The catalyst is made of palladium nanocubes coated with iridium
Gene responsible for metastasis of breast cancer to the bone identified Physicians currently have no tools to help them detect which breast cancer patients will suffer metastasis to the bone, a process that occurs in 15-20 percent of cases. A new study has uncovered a gene that allows breast cancer cells to invade bones and create new tumors, or to metastasize.
Scientists discover how cells overpower cancer drug Scientists have found how cells adapt to overcome cancer drugs designed to interfere with their genetic controls.These findings could help develop future therapies that override the survival mechanism in tumor types that don't respond

No comments:

Post a Comment